Low serum osteoprotegerin levels in premenopausal infertile women with low bone density: an association of relevance?

John M. Norian, Gohar Zeitlian, Goli Adel, Ruth G. Freeman, Nanette F. Santoro, Lubna Pal

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To evaluate if the levels of the central regulators of osteoclast activity, osteoprotegerin (OPG) and receptor activator for nuclear factor κB-ligand (RANk-L), correlate with bone mineral density (BMD) parameters in premenopausal infertile women. Design: Cross-sectional study. Setting: Academic infertility practice. Patient(s): 82 Infertile, but otherwise healthy, premenopausal women< 42 years age presenting for routine care. Intervention(s): BMD assessment; serum samples (cycle days 1 to 3), questionnaire addressing demographics, medical, social, family, and personal histories. Main Outcome Measure(s): BMD categorized as "Low" (Z ≤ -1.0) or "Normal" (Z > -1.0); Biomarkers of bone metabolism (BAP, TRAP, NTX, OPG, RANK-L) and ovarian reserve (FSH, estradiol). Result(s): The prevalence of low BMD was 23% (19/82). Significantly lower levels of OPG were observed in association with low BMD compared with normal BMD (1.37 ± 0.57 versus 2.0 ± 1.05 pMol/L). Multivariable logistic regression analyses revealed low OPG levels as independent predictors of low BMD after adjusting for parameters known to influence bone density. Conclusion(s): We demonstrate an independent relationship between low circulating levels of OPG and low BMD in premenopausal healthy, albeit infertile, women.

Original languageEnglish (US)
Pages (from-to)542-548
Number of pages7
JournalFertility and Sterility
Volume91
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Osteoprotegerin
Bone Density
Serum
Osteoclasts
Cytoplasmic and Nuclear Receptors
Infertility
Estradiol
Cross-Sectional Studies
Biomarkers
Logistic Models
Regression Analysis
Ligands
Bone and Bones

Keywords

  • BMD
  • infertility
  • Osteoprotegerin
  • premenopause
  • RANKL

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Low serum osteoprotegerin levels in premenopausal infertile women with low bone density : an association of relevance? / Norian, John M.; Zeitlian, Gohar; Adel, Goli; Freeman, Ruth G.; Santoro, Nanette F.; Pal, Lubna.

In: Fertility and Sterility, Vol. 91, No. 2, 02.2009, p. 542-548.

Research output: Contribution to journalArticle

Norian, John M. ; Zeitlian, Gohar ; Adel, Goli ; Freeman, Ruth G. ; Santoro, Nanette F. ; Pal, Lubna. / Low serum osteoprotegerin levels in premenopausal infertile women with low bone density : an association of relevance?. In: Fertility and Sterility. 2009 ; Vol. 91, No. 2. pp. 542-548.
@article{41acf996b0d54232aecac98dd58f3d65,
title = "Low serum osteoprotegerin levels in premenopausal infertile women with low bone density: an association of relevance?",
abstract = "Objective: To evaluate if the levels of the central regulators of osteoclast activity, osteoprotegerin (OPG) and receptor activator for nuclear factor κB-ligand (RANk-L), correlate with bone mineral density (BMD) parameters in premenopausal infertile women. Design: Cross-sectional study. Setting: Academic infertility practice. Patient(s): 82 Infertile, but otherwise healthy, premenopausal women< 42 years age presenting for routine care. Intervention(s): BMD assessment; serum samples (cycle days 1 to 3), questionnaire addressing demographics, medical, social, family, and personal histories. Main Outcome Measure(s): BMD categorized as {"}Low{"} (Z ≤ -1.0) or {"}Normal{"} (Z > -1.0); Biomarkers of bone metabolism (BAP, TRAP, NTX, OPG, RANK-L) and ovarian reserve (FSH, estradiol). Result(s): The prevalence of low BMD was 23{\%} (19/82). Significantly lower levels of OPG were observed in association with low BMD compared with normal BMD (1.37 ± 0.57 versus 2.0 ± 1.05 pMol/L). Multivariable logistic regression analyses revealed low OPG levels as independent predictors of low BMD after adjusting for parameters known to influence bone density. Conclusion(s): We demonstrate an independent relationship between low circulating levels of OPG and low BMD in premenopausal healthy, albeit infertile, women.",
keywords = "BMD, infertility, Osteoprotegerin, premenopause, RANKL",
author = "Norian, {John M.} and Gohar Zeitlian and Goli Adel and Freeman, {Ruth G.} and Santoro, {Nanette F.} and Lubna Pal",
year = "2009",
month = "2",
doi = "10.1016/j.fertnstert.2007.11.089",
language = "English (US)",
volume = "91",
pages = "542--548",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Low serum osteoprotegerin levels in premenopausal infertile women with low bone density

T2 - an association of relevance?

AU - Norian, John M.

AU - Zeitlian, Gohar

AU - Adel, Goli

AU - Freeman, Ruth G.

AU - Santoro, Nanette F.

AU - Pal, Lubna

PY - 2009/2

Y1 - 2009/2

N2 - Objective: To evaluate if the levels of the central regulators of osteoclast activity, osteoprotegerin (OPG) and receptor activator for nuclear factor κB-ligand (RANk-L), correlate with bone mineral density (BMD) parameters in premenopausal infertile women. Design: Cross-sectional study. Setting: Academic infertility practice. Patient(s): 82 Infertile, but otherwise healthy, premenopausal women< 42 years age presenting for routine care. Intervention(s): BMD assessment; serum samples (cycle days 1 to 3), questionnaire addressing demographics, medical, social, family, and personal histories. Main Outcome Measure(s): BMD categorized as "Low" (Z ≤ -1.0) or "Normal" (Z > -1.0); Biomarkers of bone metabolism (BAP, TRAP, NTX, OPG, RANK-L) and ovarian reserve (FSH, estradiol). Result(s): The prevalence of low BMD was 23% (19/82). Significantly lower levels of OPG were observed in association with low BMD compared with normal BMD (1.37 ± 0.57 versus 2.0 ± 1.05 pMol/L). Multivariable logistic regression analyses revealed low OPG levels as independent predictors of low BMD after adjusting for parameters known to influence bone density. Conclusion(s): We demonstrate an independent relationship between low circulating levels of OPG and low BMD in premenopausal healthy, albeit infertile, women.

AB - Objective: To evaluate if the levels of the central regulators of osteoclast activity, osteoprotegerin (OPG) and receptor activator for nuclear factor κB-ligand (RANk-L), correlate with bone mineral density (BMD) parameters in premenopausal infertile women. Design: Cross-sectional study. Setting: Academic infertility practice. Patient(s): 82 Infertile, but otherwise healthy, premenopausal women< 42 years age presenting for routine care. Intervention(s): BMD assessment; serum samples (cycle days 1 to 3), questionnaire addressing demographics, medical, social, family, and personal histories. Main Outcome Measure(s): BMD categorized as "Low" (Z ≤ -1.0) or "Normal" (Z > -1.0); Biomarkers of bone metabolism (BAP, TRAP, NTX, OPG, RANK-L) and ovarian reserve (FSH, estradiol). Result(s): The prevalence of low BMD was 23% (19/82). Significantly lower levels of OPG were observed in association with low BMD compared with normal BMD (1.37 ± 0.57 versus 2.0 ± 1.05 pMol/L). Multivariable logistic regression analyses revealed low OPG levels as independent predictors of low BMD after adjusting for parameters known to influence bone density. Conclusion(s): We demonstrate an independent relationship between low circulating levels of OPG and low BMD in premenopausal healthy, albeit infertile, women.

KW - BMD

KW - infertility

KW - Osteoprotegerin

KW - premenopause

KW - RANKL

UR - http://www.scopus.com/inward/record.url?scp=59249086905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59249086905&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2007.11.089

DO - 10.1016/j.fertnstert.2007.11.089

M3 - Article

C2 - 18490014

AN - SCOPUS:59249086905

VL - 91

SP - 542

EP - 548

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -